NCT04461535View on ClinicalTrials.gov

Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism(ADOPA)

NACompletedINTERVENTIONAL

Enrollment

228

Participants

Timeline

Start Date

July 8, 2020

Primary Completion Date

February 20, 2023

Study Completion Date

February 20, 2023

Conditions

Primary Aldosteronism

Interventions

DRUG

Adrenocorticotropic hormone

Patients divided into Intervention group need to undergo stimulation with a continuous cosyntropin infusion (50 μg/h started 30 minutes before sampling during AVS). Right and left adrenal venous blood and corresponding peripheral venous blood should be sampled sequentially.

Trial Locations (1)

400016

The First Affilated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors

lead

Chongqing Medical University

OTHER

NCT04461535 - Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism(ADOPA) | Biotech Hunter | Biotech Hunter